Evaluating the feasibility of utilizing the small molecule phenamil as a novel biofactor for bone regenerative engineering.

Abstract

Osteoblast cell adhesion and differentiation on biomaterials are important achievements necessary for implants to be useful in bone regenerative engineering. Recombinant bone morphogenetic proteins (BMPs) have been shown to be important for these processes; however, there are many challenges associated with the widespread use of these proteins. A recent… (More)
DOI: 10.1002/term.1573

Topics

Cite this paper

@article{Lo2014EvaluatingTF, title={Evaluating the feasibility of utilizing the small molecule phenamil as a novel biofactor for bone regenerative engineering.}, author={Kevin Lo and Bret D. Ulery and Ho Man Kan and Keshia M Ashe and Cato Laurencin}, journal={Journal of tissue engineering and regenerative medicine}, year={2014}, volume={8 9}, pages={728-36} }